Induced pluripotent stem cells from fetal skin cells and embryonic stem cells display comparable potential for derivation of hepatocytes

Numerous patients suffering from chronic liver diseases are currently receiving inadequate treatment due to the lack of organs donated for transplantation. However, hepatocytes derived from induced pluripotent stem cells (iPSCs) could offer an alternative for the future. Scientists compared hepatocytes from embryonic stem cells with hepatocytes from iPS cells and found that their gene expression is very similar.

Read the whole article on Science Daily

More from Science Daily